"To get a benefit, people have to receive the drug within the early stages of disease – once hospitalized with COVID-19, the drug does nothing to help, a Lilly study has shown."

Patients may not learn about the drugs until it's too late, though.

Brilacidin is for Moderate to severe which are hospitalized patients.